OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New markers in Parkinson's disease
Anastasia Bougea
Advances in clinical chemistry (2020), pp. 137-178
Closed Access | Times Cited: 23
Anastasia Bougea
Advances in clinical chemistry (2020), pp. 137-178
Closed Access | Times Cited: 23
Showing 23 citing articles:
A Systematic Review of Artificial Intelligence (AI) Based Approaches for the Diagnosis of Parkinson’s Disease
S. Saravanan, K. Ramkumar, K. Adalarasu, et al.
Archives of Computational Methods in Engineering (2022) Vol. 29, Iss. 6, pp. 3639-3653
Closed Access | Times Cited: 50
S. Saravanan, K. Ramkumar, K. Adalarasu, et al.
Archives of Computational Methods in Engineering (2022) Vol. 29, Iss. 6, pp. 3639-3653
Closed Access | Times Cited: 50
Mitochondriopathies as a Clue to Systemic Disorders—Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2007-2007
Open Access | Times Cited: 41
Alena Líšková, Marek Samec, Lenka Koklesová, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 2007-2007
Open Access | Times Cited: 41
A comparative study: prediction of parkinson’s disease using machine learning, deep learning and nature inspired algorithm
Pankaj Kumar Keserwani, Suman R. Das, Nairita Sarkar
Multimedia Tools and Applications (2024) Vol. 83, Iss. 27, pp. 69393-69441
Closed Access | Times Cited: 7
Pankaj Kumar Keserwani, Suman R. Das, Nairita Sarkar
Multimedia Tools and Applications (2024) Vol. 83, Iss. 27, pp. 69393-69441
Closed Access | Times Cited: 7
Some Novel Therapies in Parkinson’s Disease: A Promising Path Forward or Not Yet? A Systematic Review of the Literature
Anastasia Bougea
Biomedicines (2024) Vol. 12, Iss. 3, pp. 549-549
Open Access | Times Cited: 7
Anastasia Bougea
Biomedicines (2024) Vol. 12, Iss. 3, pp. 549-549
Open Access | Times Cited: 7
Voice biomarkers as prognostic indicators for Parkinson’s disease using machine learning techniques
Ifrah Naeem, Allah Ditta, Tehseen Mazhar, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Ifrah Naeem, Allah Ditta, Tehseen Mazhar, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The major histocompatibility complex participates in Parkinson’s disease
Rou Gu, Jianyu Pan, Maher Un Nisa Awan, et al.
Pharmacological Research (2024) Vol. 203, pp. 107168-107168
Open Access | Times Cited: 4
Rou Gu, Jianyu Pan, Maher Un Nisa Awan, et al.
Pharmacological Research (2024) Vol. 203, pp. 107168-107168
Open Access | Times Cited: 4
Correlates of Zonulin and Claudin-5, markers of intestinal and brain endothelial permeability, in Parkinson's Disease: A pilot study
Sena Boncuk Ulaş, Yeşim Güzey Aras, Sezen Irmak Gözükara, et al.
Parkinsonism & Related Disorders (2023) Vol. 110, pp. 105361-105361
Closed Access | Times Cited: 8
Sena Boncuk Ulaş, Yeşim Güzey Aras, Sezen Irmak Gözükara, et al.
Parkinsonism & Related Disorders (2023) Vol. 110, pp. 105361-105361
Closed Access | Times Cited: 8
Abnormalities in Copper Status Associated with an Elevated Risk of Parkinson’s Phenotype Development
Marina N. Karpenko, Zamira M. Muruzheva, Ekaterina Y. Ilyechova, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1654-1654
Open Access | Times Cited: 7
Marina N. Karpenko, Zamira M. Muruzheva, Ekaterina Y. Ilyechova, et al.
Antioxidants (2023) Vol. 12, Iss. 9, pp. 1654-1654
Open Access | Times Cited: 7
Effectiveness and safety of different catechol-o-methyl transferase inhibitors for patients with parkinson’s disease: Systematic review and network meta-analysis
Wenshuo Wu, Xiaohui Lu, Liping Zhang, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 239, pp. 108189-108189
Closed Access | Times Cited: 2
Wenshuo Wu, Xiaohui Lu, Liping Zhang, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 239, pp. 108189-108189
Closed Access | Times Cited: 2
Identification of Key Genes and Immunological Features Associated with Copper Metabolism in Parkinson’s Disease by Bioinformatics Analysis
Haofuzi Zhang, Jun Nagai, Hao Lü, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 2, pp. 799-811
Closed Access | Times Cited: 6
Haofuzi Zhang, Jun Nagai, Hao Lü, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 2, pp. 799-811
Closed Access | Times Cited: 6
Role of microRNAs in cognitive decline related to COVID‑19 (Review)
Anastasia Bougea, Vasiliki Georgakopoulou, Ioannis Lempesis, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 1
Anastasia Bougea, Vasiliki Georgakopoulou, Ioannis Lempesis, et al.
Experimental and Therapeutic Medicine (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 1
Calcium/calmodulin-dependent serine protein kinase exacerbates mitochondrial calcium uniporter-related mitochondrial calcium overload by phosphorylating α-synuclein in Parkinson’s disease
Qingxi Zhang, Yin Huang, Anbiao Wu, et al.
The International Journal of Biochemistry & Cell Biology (2023) Vol. 157, pp. 106385-106385
Closed Access | Times Cited: 4
Qingxi Zhang, Yin Huang, Anbiao Wu, et al.
The International Journal of Biochemistry & Cell Biology (2023) Vol. 157, pp. 106385-106385
Closed Access | Times Cited: 4
Kinect-based objective evaluation of bradykinesia in patients with Parkinson's disease
Zhuang Wu, Hongkai Gu, Ronghua Hong, et al.
Digital Health (2023) Vol. 9
Open Access | Times Cited: 4
Zhuang Wu, Hongkai Gu, Ronghua Hong, et al.
Digital Health (2023) Vol. 9
Open Access | Times Cited: 4
Digital biomarkers in Parkinson’s disease
Anastasia Bougea
Advances in clinical chemistry (2024), pp. 221-253
Closed Access | Times Cited: 1
Anastasia Bougea
Advances in clinical chemistry (2024), pp. 221-253
Closed Access | Times Cited: 1
Seeding Aggregation Assays in Lewy Bodies Disorders: A Narrative State-of-the-Art Review
Anastasia Bougea
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10783-10783
Open Access | Times Cited: 1
Anastasia Bougea
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10783-10783
Open Access | Times Cited: 1
microRNA and circRNA in Parkinson’s Disease and atypical parkinsonian syndromes
Anastasia Bougea, Leonidas Stefanis
Advances in clinical chemistry (2023), pp. 83-133
Closed Access | Times Cited: 2
Anastasia Bougea, Leonidas Stefanis
Advances in clinical chemistry (2023), pp. 83-133
Closed Access | Times Cited: 2
PBX1 attenuates 6-OHDA-induced oxidative stress and apoptosis and affects PINK1/PARKIN expression in dopaminergic neurons via FOXA1
Binglong Li, Di An, Shasha Zhu
Cytotechnology (2022) Vol. 74, Iss. 2, pp. 217-229
Open Access | Times Cited: 4
Binglong Li, Di An, Shasha Zhu
Cytotechnology (2022) Vol. 74, Iss. 2, pp. 217-229
Open Access | Times Cited: 4
A bibliometric analysis of neuroimaging biomarkers in Parkinson disease based on Web of Science
Xiaoling Li, Rui-Xue Gao, Qinhong Zhang, et al.
Medicine (2022) Vol. 101, Iss. 33, pp. e30079-e30079
Open Access | Times Cited: 4
Xiaoling Li, Rui-Xue Gao, Qinhong Zhang, et al.
Medicine (2022) Vol. 101, Iss. 33, pp. e30079-e30079
Open Access | Times Cited: 4
Microfabrication atomic layer deposited Pt NPs/TiN thin film on silicon as a nanostructure signal Transducer: Electrochemical characterization toward neurotransmitter sensing
Yalda Shoja, Noora Isoaho, Ville Jokinen, et al.
Applied Surface Science (2021) Vol. 573, pp. 151444-151444
Open Access | Times Cited: 5
Yalda Shoja, Noora Isoaho, Ville Jokinen, et al.
Applied Surface Science (2021) Vol. 573, pp. 151444-151444
Open Access | Times Cited: 5
REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's disease
A. Ahnaou, Wilhelmus Drinkenburg
Neuroscience & Biobehavioral Reviews (2022) Vol. 143, pp. 104897-104897
Closed Access | Times Cited: 3
A. Ahnaou, Wilhelmus Drinkenburg
Neuroscience & Biobehavioral Reviews (2022) Vol. 143, pp. 104897-104897
Closed Access | Times Cited: 3
Unveiling Parkinson’s disease through biomarker research: current insights and future prospects
Nazlı Durmaz Çelik, Serkan Özben, Tomris Özben
Critical Reviews in Clinical Laboratory Sciences (2024), pp. 1-17
Closed Access
Nazlı Durmaz Çelik, Serkan Özben, Tomris Özben
Critical Reviews in Clinical Laboratory Sciences (2024), pp. 1-17
Closed Access
Diagnosis and biomarkers of Parkinson's disease and related movement disorders
Mahmoud Ahmed Ebada, Adel Mouffokes, Muhammad Imran, et al.
Elsevier eBooks (2024), pp. 39-63
Closed Access
Mahmoud Ahmed Ebada, Adel Mouffokes, Muhammad Imran, et al.
Elsevier eBooks (2024), pp. 39-63
Closed Access
Biomarkers for Diagnosing and Treating Fetal Growth Restriction
Mengyao Wu, Junyu He, Yetao Chen, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 28, pp. 4461-4478
Closed Access | Times Cited: 1
Mengyao Wu, Junyu He, Yetao Chen, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 28, pp. 4461-4478
Closed Access | Times Cited: 1
